Drug intelligence / Profile preview

D-Fibroheal Particle

Development stage: Unknown
Lead developer: Fibroheal Woundcare
Modality: Recombinant Proteins and Enzymes
Administration: Topical

Overview

D-Fibroheal Particle is a topical wound care product developed by Fibroheal Woundcare Pvt. Ltd., a biotech company specializing in silk protein-based biomaterials. The product consists of pure lyophilized silk protein in a bio-absorbable particulate form. When applied to wounds or ulcers, these particles provide a high-surface-area biomaterial scaffold that facilitates the formation of fibroblasts and enhances epithelialization. This structural support promotes advanced wound healing and offers improved bioavailability and contact with the wound bed compared to traditional dressings.

Brand names: D-Fibroheal Particle
Other names: Fibroheal Particle

Beyond the preview

Go deeper on D-Fibroheal Particle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-Fibroheal Particle.

Explore the full profile